Published in Cancer Weekly, April 29th, 2003
In a laboratory-based pilot study, published in the British Journal of Cancer, researchers took blood cells from patients with advanced bowel cancer and turned them into potent cancer killers.
The technique involves engineering patients' white blood cells - the foot soldiers of the immune system - to recognize and destroy tumors. Scientists now intend to begin the U.K.'s first trial of the treatment, which they hope will transform the prospects of many people with bowel...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.